Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2011
07/05/2011US7972601 Method of promoting delivery of an antioxidant agent to a cell expression neuroligin
07/05/2011CA2548887C Method of modifying plant phenotypes with nonsymbiotic hemoglobin
07/05/2011CA2521382C Method for the construction of randomized gene sequence libraries in cells
07/05/2011CA2488630C Immunoadhesin comprising a glycoprotein vi domain
07/05/2011CA2466629C Expression control using variable intergenic sequences
07/05/2011CA2401491C Ccr4-binding antibody and diagnostic and therapeutic uses thereof
07/05/2011CA2390081C Modified viral surface proteins which bind to cells of tumor vasculature
07/05/2011CA2389391C Use of a class of enzymes and their encoding genes to increase the oil content in transgenic organisms
07/05/2011CA2380066C Antitumor antibodies, proteins, and uses thereof
07/05/2011CA2345027C Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
07/05/2011CA2319714C Plant having altered environmental stress tolerance
07/05/2011CA2288994C Polyalkylene oxide-modified single chain polypeptides
07/05/2011CA2220133C Recombinant vesiculoviruses and their uses
07/05/2011CA2204636C Diagnostic method and kit for determining kell blood group genotype
06/2011
06/30/2011WO2011079307A2 Methods and compositions for treating neurological disorders
06/30/2011WO2011079272A1 Compounds for modulating the switch between replication and transcription of orthomyxovirus viral genomes and methods of use thereof
06/30/2011WO2011079263A2 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
06/30/2011WO2011079261A2 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
06/30/2011WO2011079070A1 Furin-knockdown bi-functional rna
06/30/2011WO2011079005A1 Plant membrane bound o-acyl transferase (mboat) family protein sequences and their uses for altering fatty acid compositions
06/30/2011WO2011078897A1 Improved sequencing methods, compositions, systems, kits and apparatuses
06/30/2011WO2011078807A2 High-performance isolation of nucleic acids
06/30/2011WO2011078778A1 Method for assessing the sensitisation capability of a compound
06/30/2011WO2011078672A1 Molecule for treating an inflammatory disorder
06/30/2011WO2011078665A1 Improved techniques for transfecting protoplasts
06/30/2011WO2011078662A1 Dsrna for improved genetic modification of plant dna
06/30/2011WO2011078495A2 Chemo-sensitive prediction method for snp
06/30/2011WO2011078456A1 Human antibodies specifically binding to the hepatitis b virus surface antigen
06/30/2011WO2011078448A1 Metagenome-derived alkaline phosphatase
06/30/2011WO2011078443A1 Detecting marker for gastric cancer and detecting method using the same marker
06/30/2011WO2011078441A1 Tsg primer target detection
06/30/2011WO2011078439A1 Real-time multiplexing detection of target nucleic acid sequences with elimination of false signals
06/30/2011WO2011078393A1 Plant overexpressing abscisic acid transporter protein and method for creating the same
06/30/2011WO2011078351A1 Secretion signal sequence, and protein expression system utilizing same
06/30/2011WO2011078338A1 Protein having novel terpene synthase activity and gene encoding same
06/30/2011WO2011078332A1 Polypeptide modification method for purifying polypeptide multimers
06/30/2011WO2011078308A1 GENE Dro1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME
06/30/2011WO2011078262A1 Xylose isomerase and use thereof
06/30/2011WO2011078250A1 Radiolabeled compound directable in vivo to target tissue and use thereof
06/30/2011WO2011078223A1 Method for analyzing cervical lymph node metastasis, and tumor marker for head and neck cancer
06/30/2011WO2011078134A1 Diacylglycerole acyltranferase gene, and use thereof
06/30/2011WO2011078094A1 Method for detection and quantification of wheat endogenous gene
06/30/2011WO2011078093A1 Method for qualitative and quantitative detection of common wheat
06/30/2011WO2011078037A1 Aging marker, method for evaluating aging inhibitor, and cancer inhibitor
06/30/2011WO2011077990A1 PROBES FOR DETECTION OF POLYMORPHISMS OF c-kit GENE, AND USE THEREOF
06/30/2011WO2011077931A1 Method for producing fatty acid-containing lipid using thioesterase variant
06/30/2011WO2011077371A1 Method for enhancing the expression of hpv l1
06/30/2011WO2011077143A1 Transformation of commensal neisseria
06/30/2011WO2011077133A2 Method of treatment and screening method
06/30/2011WO2011077075A1 Orthogonal q-ribosomes
06/30/2011WO2011077004A1 Mutagenesis method
06/30/2011WO2011076970A1 Bioactive surface capable of genetically modifying biological cells or tissues and use thereof
06/30/2011WO2011076933A1 Method of transforming cells
06/30/2011WO2011076892A1 Plants tolerant to hppd inhibitor herbicides
06/30/2011WO2011076889A1 Plants tolerant to hppd inhibitor herbicides
06/30/2011WO2011076885A1 Plants tolerant to hppd inhibitor herbicides
06/30/2011WO2011076882A1 Plants tolerant to hppd inhibitor herbicides
06/30/2011WO2011076877A1 Plants tolerant to hppd inhibitor herbicides
06/30/2011WO2011076873A1 Influenza targets
06/30/2011WO2011076870A1 Promoter sequences
06/30/2011WO2011076794A1 Isolated plant gdsl lipase
06/30/2011WO2011076345A1 Herbicide tolerant plants
06/30/2011WO2011076145A1 Tissue-based micro-rna methods for diagnosis of different subtypes of lung cancer
06/30/2011WO2011076144A1 Compositions and methods for microrna expession profiling in plasma of lung cancer
06/30/2011WO2011076123A1 Compositions comprising boosting polypeptide and starch degrading enzyme and uses thereof
06/30/2011WO2011075838A1 Method of treating or preventing hearing loss
06/30/2011WO2011060613A9 Human alpha-defensin 5 mutant polypeptide and preparation method and use thereof
06/30/2011WO2011057011A3 T-cell stimulating protein b and methods of use
06/30/2011WO2011031438A3 Porcine torque teno virus vaccines and diagnosis
06/30/2011WO2011010870A3 Genetic marker for predicting the survival of a patient with early-stage lung cancer, and method for predicting survival using same
06/30/2011WO2011008303A3 Designer collagens and uses thereof
06/30/2011WO2010148065A3 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
06/30/2011WO2010137900A3 Selective infracted-tissue-targeting bacteria and use thereof
06/30/2011WO2010059914A8 Nucleic acid quantification products and processes
06/30/2011US20110162115 Recombinant ndv antigen and uses thereof
06/30/2011US20110162114 Selection method ii
06/30/2011US20110162113 Antibodies
06/30/2011US20110162112 Increasing time-efficiency of high-throughput transformation processes
06/30/2011US20110162111 Method for transforming somatic embryos
06/30/2011US20110162109 Plants Having Modified Growth Characteristics and a Method for Making the Same
06/30/2011US20110162108 Nucleotide sequences encoding ramosa3 and sister of ramosa3 and methods of use for same
06/30/2011US20110162107 Plants having improved growth characteristics and methods for making the same
06/30/2011US20110162106 Plant expression constructs comprising and uses thereof
06/30/2011US20110162105 Nucleic Acids Encoding Desaturases and Modified Plant Oil
06/30/2011US20110162104 Plant Membrane Bound O-Acyl Transferase (MBOAT) Family Protein Sequences And Their Uses For Altering Fatty Acid Compositions
06/30/2011US20110162103 Nucleic acid molecules encoding wrinkled1-like polypeptides and methods of use in plants
06/30/2011US20110162102 Novel root-knot-nematode-resistance gene and application thereof
06/30/2011US20110162101 Plant Transcription Factors
06/30/2011US20110162096 Gene Therapy Using Transposon-Based Vectors
06/30/2011US20110162094 Modified human factor vii/viia and pharmaceutical composition containing the same
06/30/2011US20110160445 Heparin-Binding Growth Factor (HBGF) Polypeptides
06/30/2011US20110160443 Rna aptamers and methods for identifying the same
06/30/2011US20110160438 Il-17 receptor like molecules and uses thereof
06/30/2011US20110160293 Prmt1 for target genes of cancer therapy and diagnosis
06/30/2011US20110160292 Regulation of Integrin Surface Expression
06/30/2011US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis
06/30/2011US20110160288 Oip5 as a target gene for cancer therapy and diagnosis
06/30/2011US20110160286 Allele-specific rna interference
06/30/2011US20110160284 Supercoiled minicircle dna for gene therapy applications
06/30/2011US20110160283 Modulation of cd40 expression